Augmentin DF Oral Solution Dosing Compared to Tablet
Augmentin oral solution and tablet formulations are NOT interchangeable due to different clavulanate content, and substitution between formulations should never be made without careful attention to the specific clavulanate-to-amoxicillin ratios.
Critical Formulation Differences
The fundamental issue is that different Augmentin formulations contain varying amounts of clavulanic acid relative to amoxicillin, making direct substitution inappropriate 1:
- Augmentin ES-600 suspension: 600 mg amoxicillin/42.9 mg clavulanate per 5 mL (14:1 ratio)
- Standard Augmentin 200 mg/5 mL suspension: 200 mg amoxicillin/28.5 mg clavulanate per 5 mL (7:1 ratio)
- Standard Augmentin 400 mg/5 mL suspension: 400 mg amoxicillin/57 mg clavulanate per 5 mL (7:1 ratio)
- Augmentin tablets (875 mg): 875 mg amoxicillin/125 mg clavulanate (7:1 ratio)
Pediatric Dosing Guidelines
High-Dose Regimen (for resistant pathogens)
For children aged 3 months to 12 years weighing ≤40 kg with recurrent/persistent infections or risk factors for resistant organisms 2, 1:
- Augmentin ES-600: 90 mg/kg/day of amoxicillin component divided every 12 hours (provides 6.4 mg/kg/day clavulanate)
- Duration: 10 days 2
- Administration: At the start of meals to minimize GI intolerance and enhance clavulanate absorption 1
Standard-Dose Regimen
For uncomplicated infections 3, 4:
- Amoxicillin-clavulanate: 25 mg/kg/day of amoxicillin component in 2 divided doses (using standard 7:1 ratio formulations)
- Alternative: 40 mg/kg/day in 3 divided doses for carrier states 2
Adult Dosing Guidelines
Standard Dosing
For most community-acquired infections 3, 4, 5:
- Augmentin 875/125 mg tablet: One tablet twice daily
- Duration: 5-7 days for uncomplicated acute bacterial rhinosinusitis 6; 10 days for skin/soft tissue infections 3, 4
High-Dose Regimen
For suspected resistant pathogens (particularly penicillin-nonsusceptible S. pneumoniae) 5, 6:
- High-dose amoxicillin-clavulanate: 4 g amoxicillin with 250 mg clavulanate per day (typically as 2 g/125 mg twice daily using extended-release formulation)
Critical Prescribing Pitfalls
Never substitute formulations based solely on amoxicillin content - The clavulanate dose varies significantly and affects both efficacy and tolerability 1
Adults cannot use Augmentin ES-600 - This formulation is specifically designed for pediatric use and should not be given to adults who have difficulty swallowing tablets 1
Children >40 kg require different dosing - Experience with ES-600 in this population is not available; use adult formulations instead 1
Clavulanate dose limits - In adults, clavulanate is restricted to 125 mg per dose due to tolerability issues, primarily diarrhea 7
Tolerability Considerations
Twice-daily dosing with appropriate amoxicillin-to-clavulanate ratios significantly reduces diarrhea compared to three-times-daily regimens. The high-dose pediatric formulation (14:1 ratio) causes substantially less diarrhea than older 4:1 ratio formulations while maintaining equivalent efficacy 8, 9:
- Diarrhea incidence with 4:1 ratio (three times daily): 26.7%
- Diarrhea incidence with 14:1 ratio (twice daily): 8.7-9.6% 8
Storage and Preparation
When Formulation Switching Is Necessary
If a patient requires transition between oral solution and tablets (e.g., child reaching appropriate age/weight):
- Calculate the total daily amoxicillin dose needed
- Select the appropriate formulation that provides the correct amoxicillin AND clavulanate ratio for the indication
- Verify the clavulanate content matches clinical requirements
- Never assume equivalent dosing based on amoxicillin content alone
The key principle is that each formulation is designed for specific clinical scenarios with optimized amoxicillin-to-clavulanate ratios, and substitution requires careful recalculation of both components 1.